En Hyung Chang1, Angela C Brown1. 1. Department of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA, USA.
Abstract
OBJECTIVES: We and others have previously shown that epigallocatechin gallate (EGCg) inhibits the activity of an important virulence factor, leukotoxin (LtxA), produced by the oral bacterium Aggregatibacter actinomycetemcomitans, suggesting the potential use of this molecule as an anti-virulence strategy to treat periodontal infections. Here, we sought to better understand the effects of EGCg on toxin secretion and A. actinomycetemcomitans pathogenicity in a co-culture model. METHODS: We used a quantitative immunoblot assay to determine the concentrations of LtxA in the bacterial supernatant and on the bacterial cell surface. Using a co-culture model, consisting of A. actinomycetemcomitans and THP-1 cells, we studied the impact of EGCg-mediated changes in LtxA secretion on the toxicity of A. actinomycetemcomitans. KEY FINDINGS: EGCg increased production of LtxA and changed the localization of secreted LtxA from the supernatant to the surface of the bacterial cells. In the co-culture model, a single low dose of EGCg did not protect host THP-1 cells from A. actinomycetemcomitans-mediated cytotoxicity, but a multiple dosing strategy had improved effects. CONCLUSIONS: Together, these results demonstrate that EGCg has important, but complicated, effects on toxin secretion and activity; new dosing strategies and comprehensive model systems may be required to properly develop these anti-virulence activities.
OBJECTIVES: We and others have previously shown that epigallocatechin gallate (EGCg) inhibits the activity of an important virulence factor, leukotoxin (LtxA), produced by the oral bacterium Aggregatibacter actinomycetemcomitans, suggesting the potential use of this molecule as an anti-virulence strategy to treat periodontal infections. Here, we sought to better understand the effects of EGCg on toxin secretion and A. actinomycetemcomitans pathogenicity in a co-culture model. METHODS: We used a quantitative immunoblot assay to determine the concentrations of LtxA in the bacterial supernatant and on the bacterial cell surface. Using a co-culture model, consisting of A. actinomycetemcomitans and THP-1 cells, we studied the impact of EGCg-mediated changes in LtxA secretion on the toxicity of A. actinomycetemcomitans. KEY FINDINGS: EGCg increased production of LtxA and changed the localization of secreted LtxA from the supernatant to the surface of the bacterial cells. In the co-culture model, a single low dose of EGCg did not protect host THP-1 cells from A. actinomycetemcomitans-mediated cytotoxicity, but a multiple dosing strategy had improved effects. CONCLUSIONS: Together, these results demonstrate that EGCg has important, but complicated, effects on toxin secretion and activity; new dosing strategies and comprehensive model systems may be required to properly develop these anti-virulence activities.
Authors: Jesper Reinholdt; Knud Poulsen; Christel R Brinkmann; Søren V Hoffmann; Romualdas Stapulionis; Jan J Enghild; Uffe B Jensen; Thomas Boesen; Thomas Vorup-Jensen Journal: Biochim Biophys Acta Date: 2012-12-09
Authors: V I Haraszthy; G Hariharan; E M Tinoco; J R Cortelli; E T Lally; E Davis; J J Zambon Journal: J Periodontol Date: 2000-06 Impact factor: 6.993
Authors: Daniel H Fine; Kenneth Markowitz; David Furgang; Karen Fairlie; Javier Ferrandiz; Cebile Nasri; Marie McKiernan; John Gunsolley Journal: J Clin Microbiol Date: 2007-10-17 Impact factor: 5.948
Authors: Laura C Ristow; Vy Tran; Kevin J Schwartz; Lillie Pankratz; Andrew Mehle; John-Demian Sauer; Rodney A Welch Journal: mBio Date: 2019-07-09 Impact factor: 7.867